Molecular profiling may soon guide endometrial cancer treatment decisions

In this video, Robert DeBernardo, MD, discusses
the prognostic potential of molecular profiling to treat endometrial cancer, a
topic presented at Society of Gynecologic Oncology Annual Meeting on Women’s
Cancer.

DeBernardo, section head of the department of obstetrics and
gynecology and Women’s Health Institute at Cleveland Clinic, expects more
research in this area in the coming years.

“We’ve known that these molecular profiles have existed for
a while and we’ve recognized that there’s prognostic impacts to them, but now
we’re starting to treat people according to these [profiles],” DeBernardo said.

Published by:

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

“
data-action=”subscribe”>
Subscribe

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio